Genotyping BRCA1, BRCA2, and PALB2 French-Canadian breast cancer variants identified a pathogenic variant in 3.8% (21/555) of breast cancer cases unselected for age or family history and 0.2% (5/1940) of cancer-free controls. This evidence concerns the gene BRCA1 and cancer.